🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher M. Bailey

University of Maryland, Baltimore

ORCID: 0000-0002-5962-9511

Also affiliated with William & Mary, Moderna Therapeutics (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular BiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues”.

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues

Journal of Clinical Investigation(2022)10.1172/jci150846
N/A
0.748DataRank · unranked
145 citations

Yan Liu, Mingyue Liu, Xuexiang Du, Martin Devenport, Pan Zheng +3 more

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0663
N/A
0.494DataRank · unranked
26 citations

Prerna Singh, Christopher M. Bailey, Jonelle K. Lee, Shivani Kapoor, Rena G. Lapidus +7 more

Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102278
N/A
0DataRank · unranked
45 citations

Yan Liu, Gong Peng, Huixia Zhang, Miao He, Duxin Sun +4 more

Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma

Cancers(2021)10.3390/cancers13040694
N/A
0DataRank · unranked
15 citations

Yan Liu, Yan Liu, Yin Wang, Christopher M. Bailey, Pan Zheng +2 more

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101236
N/A
0DataRank · unranked
5 citations

Yuanyi Wei, Jinsong Yan, Dan Huang, Peng Zhang, Chong Qi +9 more

Supplementary Tables and Figures from PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation

INDIGO (University of Illinois at Chicago)(2023)10.1158/1535-7163.22522443.v1
N/A
0DataRank · unranked
0 citations

Prerna Singh, Christopher M. Bailey, Jonelle K. Lee, Shivani Kapoor, Rena G. Lapidus +7 more